ARTICLE | Financial News
Northwest trims IPO price
December 10, 2001 8:00 AM UTC
Northwest Biotherapeutics reduced to $8-$10 from $9-$11 the price range on its proposed 3.5 million-share IPO. The company, which is developing dendritic cell-based cancer vaccines, originally filed t...